Welcome to Axiogenesis! Willkommen bei Axiogenesis!
Since 2000, Axiogenesis has been in business to capture the promise of stem cells to revolutionize the fields of drug discovery, safety/tox & life sciences research. Axiogenesis develops and commercializes stem cell-derived, in vitro-differentiated cardiomyocytes, neurons and other cells, as well as drug development assays and disease models, to help researchers discover cures.
Axiogenesis offers human iPSC-derived cardiomyocytes (Cor.4U®), peripheral neurons (Peri.4U™) and dopaminergic neurons (Dopa.4U™).